Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment

E-ISSN： 1440-1746|33|2|484-491

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.2, 2018-02, pp. : 484-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 427-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 5, 2018-03 ,pp. : 657-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD163 is associated with noninvasive measures of liver fibrosis in hepatitis C virus– and hepatitis C virus/human immunodeficiency virus–infected women

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 734-735

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD163

By Møller Holger J.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 72, Iss. 1, 2012-02 ,pp. : 1-13

Informa Healthcare

Access to resources Recommend Favorite

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 812-822

John Wiley & Sons Inc

Access to resources Recommend Favorite